Chordia Therapeutics is a research and development type bioventure specializing in oncology field.
Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of cancer with high unmet medical need.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 23, 2017 | Series A | ¥1.20B | 1 |
Takeda
|
— | Detail |